Co-Host: Jay Raman, MD, FACS

At the conclusion of these activities, participants will be able to:

1. Review the mechanisms of action, efficacy, and safety of currently available targeted treatment of RCC.

2. Facilitate discussions with patients and caregivers regarding RCC treatment options.

CME Available: auau.auanet.org/node/26091

This educational series is supported by independent educational grants from:

Amgen

Astellas

AstraZeneca

Bristol-Myers Squibb

Genomic Health

Merck

Pfizer, Inc.

Sanofi Genzyme

UroGen Pharma